| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
15.61 |
% |
10.6019/CHEMBL4513141 |
| Candida albicans |
Candida albicans |
Inhibition |
4.01 |
% |
10.6019/CHEMBL4513141 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-6.91 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Inhibition |
-4.96 |
% |
10.6019/CHEMBL4513141 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
17740.7 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
21999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
26999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile acid receptor FXR |
AC50 |
6499.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile acid receptor FXR |
AC50 |
26999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile acid receptor FXR |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
9327.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
22000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bromodomain-containing protein 4 |
Delta TM |
-0.4 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
72300.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
16700.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Casein kinase I delta |
Delta TM |
-0.05 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Delta TM |
0.05 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
18999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C8 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C8 |
CL free |
3.7 |
uL/min/nmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
CL free |
70.0 |
uL/min/nmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
CL free |
nan |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
Fm |
0.02 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
Fm |
0.49 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
Km |
5700.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
Km |
25000.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
Km |
nan |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
Vmax |
0.08 |
pmol/min/pmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
Vmax |
0.35 |
pmol/min/pmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C8 |
Vmax |
nan |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
CL free |
2.0 |
uL/min/nmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
CL free |
120.0 |
uL/min/nmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
CL free |
nan |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
Fm |
0.2 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
Fm |
0.39 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
Fm |
0.41 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
Km |
8700.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
Km |
47000.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
Km |
nan |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Vmax |
0.09 |
pmol/min/pmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
Vmax |
1.0 |
pmol/min/pmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A4 |
Vmax |
nan |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A5 |
CL free |
0.19 |
uL/min/nmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A5 |
CL free |
1.4 |
uL/min/nmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A5 |
CL free |
nan |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A5 |
Km |
66000.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A5 |
Km |
150000.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A5 |
Km |
nan |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A5 |
Vmax |
0.05 |
pmol/min/pmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A5 |
Vmax |
0.08 |
pmol/min/pmol |
10.1124/dmd.112.045286 |
| Homo sapiens |
Cytochrome P450 3A5 |
Vmax |
nan |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.38 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.61 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.86 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast growth factor receptor 3 |
Delta TM |
0.18 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Delta TM |
0.38 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Guanine nucleotide-binding protein G(s), subunit alpha |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.8 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.91 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Hepatocyte |
CL |
0.13 |
uL.min-1.(10^6cells)-1 |
10.1124/dmd.112.045286 |
| Homo sapiens |
Hepatocyte |
CL |
0.75 |
uL.min-1.(10^6cells)-1 |
10.1124/dmd.112.045286 |
| Homo sapiens |
Hepatocyte |
CL |
2.4 |
uL.min-1.(10^6cells)-1 |
10.1124/dmd.112.045286 |
| Homo sapiens |
Hepatocyte |
CL |
3.3 |
uL.min-1.(10^6cells)-1 |
10.1124/dmd.112.045286 |
| Homo sapiens |
Hepatocyte |
Vmax |
5.7 |
pmol/min/10^6cells |
10.1124/dmd.112.045286 |
| Homo sapiens |
Hepatocyte |
Vmax |
23.0 |
pmol/min/10^6cells |
10.1124/dmd.112.045286 |
| Homo sapiens |
Hepatocyte |
Vmax |
28.0 |
pmol/min/10^6cells |
10.1124/dmd.112.045286 |
| Homo sapiens |
Hepatocyte |
Vmax |
80.0 |
pmol/min/10^6cells |
10.1124/dmd.112.045286 |
| Homo sapiens |
HepG2 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-11.57 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-0.28 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
Activity |
-1.83 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-1.69 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-1.62 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-1.48 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-1.0 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-0.8 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-0.65 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-0.53 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-0.5 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-0.42 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-0.4 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-0.2 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
-0.1 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
0.6 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
1.0 |
% |
10.1021/jm8013019 |
| Homo sapiens |
Homo sapiens |
Activity |
1.0 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
1.5 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
1.9 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
2.3 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
2.6 |
mU/L |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
5.2 |
mU/L |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
5.5 |
mU/L |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
5.6 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
5.7 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
6.1 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
6.7 |
mU/L |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
7.1 |
mM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
8.3 |
mU/L |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
17.3 |
mU/L |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
18.8 |
mU/L |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Activity |
23.9 |
mU/L |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
18.2 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
23.4 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
44.81 |
ng.hr.mL-1 |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
AUC |
72.4 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
77.2 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
92.3 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
95.8 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
97.2 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
97.4 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
105.9 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
115.5 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
117.1 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
AUC |
146.5 |
ng.hr.mL-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
CL |
7.7 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
7.8 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
7.8 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL/F |
7.5 |
mL.min-1.kg-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
CL/F |
7.667 |
mL.min-1.kg-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
CL/F |
8.0 |
mL.min-1.kg-1 |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.1 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.12 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
Cmax |
33.8 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
39.11 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
80.87 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
85.06 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
99.43 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
111.14 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
116.0 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
116.66 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
125.94 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
133.23 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
150.02 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Cmax |
184.93 |
nM |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Css |
0.016 |
uM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
5.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
56.0 |
% |
10.1016/j.bmc.2007.08.060 |
| Homo sapiens |
Homo sapiens |
F |
60.0 |
% |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Fa |
0.95 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
FC |
0.38 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
0.39 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
0.8 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
0.82 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
0.87 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
0.94 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
0.98 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
1.05 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
1.1 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
3.9 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
4.3 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
FC |
6.4 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.63 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
0.99 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.67 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Ratio |
1.0 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
1.2 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
1.4 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
1.6 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
1.8 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
1.9 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
2.4 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
5.0 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
7.3 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
8.1 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
Ratio |
19.0 |
None |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
T1/2 |
1.0 |
hr |
10.1124/dmd.112.045286 |
| Homo sapiens |
Homo sapiens |
T1/2 |
1.2 |
hr |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
T1/2 |
1.3 |
hr |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Tmax |
0.8 |
hr |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Tmax |
0.9 |
hr |
10.1124/dmd.110.036921 |
| Homo sapiens |
Homo sapiens |
Vdss |
0.35 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Liver microsome |
CL |
1.4 |
mL.min-1.g-1 |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
CL |
4.1 |
mL.min-1.g-1 |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
CL |
5.6 |
mL.min-1.g-1 |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
CL |
18.0 |
mL.min-1.g-1 |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
Km |
9000.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
Km |
24000.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
Km |
37000.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
Km |
47000.0 |
nM |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
Vmax |
28.0 |
pmol/min/mg |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
Vmax |
130.0 |
pmol/min/mg |
10.1124/dmd.112.045286 |
| Homo sapiens |
Liver microsome |
Vmax |
170.0 |
pmol/min/mg |
10.1124/dmd.112.045286 |
| Homo sapiens |
LXR-alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
LXR-beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MAP kinase ERK2 |
Delta TM |
-0.15 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
53900.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
23109.3 |
nM |
None |
| Homo sapiens |
Nuclear receptor subfamily 1 group I member 3 |
AC50 |
5000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peregrin |
Delta TM |
-3.67 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
P-glycoprotein 1 |
Alpha max |
0.35 |
None |
10.1021/jm101421d |
| Homo sapiens |
P-glycoprotein 1 |
Inhibition |
35.0 |
% |
10.1021/ml200293c |
| Homo sapiens |
P-glycoprotein 1 |
Inhibition |
nan |
% |
10.1021/jm101421d |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
9600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasma |
PPB |
99.1 |
% |
10.1016/j.bmcl.2011.04.133 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
25000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
398.1 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Rap guanine nucleotide exchange factor 4 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Retinoic acid receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Retinoic acid receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Retinoic acid receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Delta TM |
-0.16 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
9400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
9200.0 |
nM |
10.1021/jm8003152 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Inhibition |
76.4 |
% |
10.1021/jm8003152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
88.4 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
83.2 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
42.2 |
% |
10.1021/jm300212s |
| Homo sapiens |
Sulfonylurea receptor 1 |
IC50 |
106.0 |
nM |
10.1016/j.bmcl.2004.07.059 |
| Homo sapiens |
Sulfonylurea receptor 1 |
Kd |
50.0 |
nM |
10.1016/j.bmcl.2004.07.059 |
| Homo sapiens |
Transcription intermediary factor 1-alpha |
Delta TM |
-1.24 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Delta TM |
-0.58 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
U2OS |
Growth Rate |
0.94 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.96 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.99 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
11220.2 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
3.14 |
% |
10.6019/CHEMBL4513141 |
| Mus musculus |
Mus musculus |
Activity |
94.0 |
mg/dl |
10.1016/j.bmc.2019.06.024 |
| Mus musculus |
Mus musculus |
Activity |
160.0 |
mg/dl |
10.1016/j.bmc.2019.06.024 |
| Mus musculus |
Mus musculus |
Activity |
259.0 |
mg/dl |
10.1016/j.bmc.2019.06.024 |
| Mus musculus |
Mus musculus |
Activity |
313.0 |
mg/dl |
10.1016/j.bmc.2019.06.024 |
| Mus musculus |
Mus musculus |
Activity |
392.0 |
mg/dl |
10.1016/j.bmc.2019.06.024 |
| Mus musculus |
Mus musculus |
Inhibition |
66.1 |
% |
10.1016/j.bmc.2019.06.024 |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
35481.3 |
nM |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
8492.1 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
6.11 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
INS1(832/13) |
IC50 |
1250.0 |
nM |
10.1016/j.ejmech.2019.111912 |
| Rattus norvegicus |
INS1(832/13) |
Inhibition |
96.16 |
% |
10.1016/j.ejmech.2019.111912 |
| Rattus norvegicus |
INS1(832/13) |
Inhibition |
99.05 |
% |
10.1016/j.ejmech.2019.111912 |
| Rattus norvegicus |
Plasma |
Fu |
0.015 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.ejmech.2012.04.025 |
| Rattus norvegicus |
Rattus norvegicus |
Delta BG |
-47.0 |
% |
10.1021/jm9810349 |
| Rattus norvegicus |
Rattus norvegicus |
Delta BG |
-42.0 |
% |
10.1021/jm9810349 |
| Rattus norvegicus |
Rattus norvegicus |
Delta BG |
-40.0 |
% |
10.1021/jm9810349 |
| Rattus norvegicus |
Rattus norvegicus |
Delta BG |
-34.0 |
% |
10.1021/jm9810349 |
| Rattus norvegicus |
Rattus norvegicus |
Delta BG |
-21.0 |
% |
10.1021/jm9810349 |
| Rattus norvegicus |
Rattus norvegicus |
Delta BG |
nan |
None |
10.1021/jm9810349 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.01 |
mg.kg-1 |
10.1021/jm9810349 |
| Rattus norvegicus |
Rattus norvegicus |
Insulin release |
2.1 |
ng/islet/1h |
10.1016/j.bmcl.2004.07.059 |
| Rattus norvegicus |
Rattus norvegicus |
Insulin release |
4.0 |
ng/islet/1h |
10.1016/j.bmcl.2004.07.059 |
| Rattus norvegicus |
Rattus norvegicus |
Relative stimulation index |
63.0 |
% |
10.1016/j.bmcl.2004.07.059 |
| Rattus norvegicus |
Rattus norvegicus |
Stimulation index |
1.9 |
% |
10.1016/j.bmcl.2004.07.059 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
4.154 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
7.8 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.06595 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.05 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.08 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.78 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.4307 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
14.0 |
% |
10.1021/ml200293c |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
15.76 |
% |
10.6019/CHEMBL4513141 |
| None |
ADMET |
CL |
0.76 |
mL.min-1.g-1 |
10.1124/dmd.112.045286 |
| None |
ADMET |
CL |
1.8 |
mL.min-1.g-1 |
10.1124/dmd.112.045286 |
| None |
ADMET |
CL |
2.7 |
mL.min-1.g-1 |
10.1124/dmd.112.045286 |
| None |
ADMET |
CL |
3.7 |
mL.min-1.g-1 |
10.1124/dmd.112.045286 |
| None |
ADMET |
CL |
7.4 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
CL |
7.8 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
10.7 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
CL |
29.51 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
98.0 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
Fm |
0.18 |
None |
10.1124/dmd.112.045286 |
| None |
ADMET |
Fm |
0.19 |
None |
10.1124/dmd.112.045286 |
| None |
ADMET |
Fm |
0.63 |
None |
10.1124/dmd.112.045286 |
| None |
ADMET |
Fu |
0.000124 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
Km |
13000.0 |
nM |
10.1124/dmd.112.045286 |
| None |
ADMET |
Km |
28000.0 |
nM |
10.1124/dmd.112.045286 |
| None |
ADMET |
Km |
47000.0 |
nM |
10.1124/dmd.112.045286 |
| None |
ADMET |
Km |
53000.0 |
nM |
10.1124/dmd.112.045286 |
| None |
ADMET |
Km |
58000.0 |
nM |
10.1124/dmd.112.045286 |
| None |
ADMET |
MRT |
0.75 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Papp |
19.0 |
10^-6 cm/s |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
PPB |
99.1 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Ratio |
0.679 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
Ratio |
0.851 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
T1/2 |
0.87 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.35 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vmax |
18.0 |
pmol/min/mg |
10.1124/dmd.112.045286 |
| None |
ADMET |
Vmax |
24.0 |
pmol/min/mg |
10.1124/dmd.112.045286 |
| None |
ADMET |
Vmax |
46.0 |
pmol/min/mg |
10.1124/dmd.112.045286 |
| None |
ADMET |
Vmax |
94.0 |
pmol/min/mg |
10.1124/dmd.112.045286 |
| None |
Hepatocyte |
CL |
49.3 |
uL.min-1.(10^6cells)-1 |
10.1124/dmd.112.045732 |
| None |
Hepatocyte |
CL |
49.9 |
uL.min-1.(10^6cells)-1 |
10.1124/dmd.112.045732 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
2.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Fu |
0.015 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.5 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
No relevant target |
LogD |
2.2 |
None |
10.1016/j.bmcl.2011.04.133 |
| None |
No relevant target |
LogD |
2.3 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
No relevant target |
LogD |
3.2 |
None |
10.1016/j.bmcl.2011.04.133 |
| None |
No relevant target |
LogD7.4 |
2.31 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
pKa |
4.4 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
No relevant target |
pKa |
6.0 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
No relevant target |
pKa |
14.79 |
None |
10.1124/dmd.112.050278 |
| None |
Unchecked |
Ac50 |
0.8913 |
uM |
None |
| None |
Unchecked |
Ac50 |
17.78 |
uM |
None |
| None |
Unchecked |
AC50 |
891.3 |
nM |
None |
| None |
Unchecked |
AC50 |
17790.0 |
nM |
None |
| None |
Unchecked |
Activity |
100.0 |
% |
10.1016/j.bmcl.2008.06.081 |
| None |
Unchecked |
Activity |
100.0 |
pg/hr |
10.1016/j.bmcl.2008.06.081 |
| None |
Unchecked |
Hepatotoxicity (acute) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Potency |
5623.4 |
nM |
None |
| None |
Unchecked |
Potency |
17782.8 |
nM |
None |
| None |
Unchecked |
Potency |
20596.2 |
nM |
None |
| None |
Unchecked |
Ratio |
0.0 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.00075 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.001 |
None |
10.1093/toxsci/kft176 |